iShares Nasdaq Biotechnology
(NASDAQ: IBB)
+1.78
+0.99%
| Symbol | Value ($) |
|---|---|
| Previous Close | 180.23 |
| Open | 181.28 |
| Day's High | 182.10 |
| Day's Low | 179.75 |
| Volume | 495,594 |
| Bid | 180.88 |
| Bid Size | 400 |
| Ask | 181.90 |
| Ask Size | 100 |
| 52-Wk High | 186.98 |
| 52-Wk Low | 114.97 |
| Beta | 0.80 |
| YTD NAV Return | +31.44 |
| YTD Market Return | +31.34 |
| Inception Date | 2/5/2001 |
| Shares Outstanding | 20.59 Mil |
- Last trade 5/17/2013 4:00 PM ET
| NA |
|---|
| The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified. |
| Symbol | Value ($) |
|---|---|
| 1 Month | 7.34% |
| 3 Months | 23.72% |
| 1 Year | 44.06% |
| 3 Years* | 28.91% |
| 5 Years* | 18.49% |
- * Annualized returns
- Data through 4/29/2013 8:00 PM ET
-
Marketwire | 5/16/2013
-
Briefing.com | 5/15/2013
-
Briefing.com | 5/14/2013
-
Seeking Alpha | 5/7/2013
-
Motley Fool | 5/2/2013
-
Seeking Alpha | 4/22/2013
-
Seeking Alpha | 4/11/2013
-
Seeking Alpha | 4/8/2013
-
Seeking Alpha | 3/26/2013
-
InvestorPlace | 3/19/2013
| Symbol | Value ($) |
|---|---|
| Category | Specialty - Health |
| Morningstar Risk | Above Average |
| Morningstar Rating | |
| Morningstar Return | Above Average |
| Symbol | Value ($) |
|---|---|
| Stocks | 99.89% |
| Cash | 0.00% |
| Fixed Income | 0.00% |
| Other | 0.11% |
| NAME | % NET ASSETS |
|---|---|
| Regeneron Pharmaceuticals, Inc. | 9.41% |
| Gilead Sciences Inc | 8.32% |
| Amgen Inc | 7.63% |
| Celgene Corporation | 6.72% |
| Alexion Pharmaceuticals, Inc. | 6.22% |
| Biogen Idec Inc | 6.21% |
| Vertex Pharmaceuticals | 4.97% |
| Perrigo Company | 3.42% |
| Biomarin Pharmaceutical, Inc. | 3.13% |
| Onyx Pharmaceuticals, Inc. | 2.92% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Quotes delayed 15min, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
